Trump administration presses Congress to cut drug prices by ending industry's 'backdoor deals'

The Trump administration calls on Congress to pass its proposed ban on "backdoor deals" pharmaceutical companies cut with middlemen who get preferred status for their drugs in Medicare prescription plans.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.